[1] R.W. Peeling, D. Mabey, M.L. Kamb, X.S. Chen, J.D. Radolf, A.S. Benzaken, Syphilis, Nat. Rev. Dis. Primers. 3 (2017), 17073, https://doi.org/10.1038/ nrdp.2017.73.
[2] GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet 388 (2016) 1545–1602.
[3] L. Newman, J. Rowley, S. Vander Hoorn, et al., Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PLoS One 10 (2015), e0143304, https://doi.org/10.1371/journal.pone.0143304.
[4] M. Taylor, M. Alonso-Gonza´lez, B. Go´mez, E. Korenromp, N. Broutet, World Health Organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for Colombia, Rev. Colomb. Obstet. Ginecolog. 68 (2017) 193–201, https://doi.org/10.18597/rcog.3071.
[5] National Institute of Infectious Diseases, National epidemiological surveillance of infectious diseases. https://www.niid.go.jp/niid/en/survaillance-data-table- english.html. (Accessed 16 July 2022).
[6] B.G. Park, J.G. Yoon, J.H. Rim, A. Lee, H.S. Kim, Comparison of six automated Treponema-specific antibody assays, J. Clin. Microbiol. 54 (2016) 163–167, https://doi.org/10.1128/JCM.02593-15.
[7] T. Onoe, M. Honda, K. Matsuo, et al., Examination of the correlation between the manual and automated serological testing methods for syphilis, J. Dermatol. 39 (2012) 355–361, https://doi.org/10.1111/j.1346-8138.2011.01341.x.
[8] A. Ebel, L. Vanneste, M. Cardinaels, et al., Validation of the INNO-LIA syphilis kit as a confirmatory assay for Treponema pallidum antibodies, J. Clin. Microbiol. 38 (2000) 215–219, https://doi.org/10.1128/JCM.38.1.215-219.2000.
[9] M.F. Smikle, O.B. James, P. Prabhakar, Biological false positive serological tests for syphilis in the Jamaican population, Genitourin. Med. 66 (1990) 76–78, https://doi.org/10.1136/sti.66.2.76.
[10] L. Creegan, H.M. Bauer, M.C. Samuel, J. Klausner, S. Liska, G. Bolan, An evaluation of the relative sensitivities of the Venereal Disease Research Laboratory test and the Treponema pallidum particle agglutination test among patients diagnosed with primary syphilis, Sex. Transm. Dis. 34 (2007) 1016–1018, https://doi. org/10.1097/OLQ.0b013e3181124473.
[11] K.A. Workowski, G.A. Bolan, Centers for disease Control and prevention, sexually transmitted diseases treatment guidelines, 2015, MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.) 64 (2015) 1–137.
[12] M. Tsuboi, T. Nishijima, T. Aoki, et al., Usefulness of automated latex turbidimetric rapid plasma reagin test for diagnosis and evaluation of treatment response in syphilis in comparison with manual card test: a prospective cohort study, J. Clin. Microbiol. 56 (2018) e01003–e01018, https://doi.org/10.1128/JCM.01003- 18.
[13] M.G. Morshed, A.E. Singh, Recent trends in the serologic diagnosis of syphilis, Clin. Vaccine Immunol. 22 (2015) 137–147, https://doi.org/10.1128/CVI.00681- 14.
[14] I.U. Park, Y.F. Fakile, J.M. Chow, et al., Performance of treponemal tests for the diagnosis of syphilis, Clin. Infect. Dis. 68 (2019) 913–918, https://doi.org/ 10.1093/cid/ciy558.
[15] I.U. Park, J.M. Chow, G. Bolan, M. Stanley, J. Shieh, J.M. Schapiro, Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management, J. Infect. Dis. 204 (2011) 1297–1304, https://doi.org/10.1093/infdis/jir524.
[16] M. Janier, M. Unemo, N. Dupin, et al., European guideline on the management of syphilis, J. Eur. Acad. Dermatol. Venereol. 35 (2021) (2020) 574–588, https:// doi.org/10.1111/jdv.16946.